Dopamine agonists in Parkinson’s disease: Impact of D1-like or D2-like dopamine receptor subtype selectivity and avenues for future treatment-Reference-Cited by-同舟云学术

Dopamine agonists in Parkinson’s disease: Impact of D1-like or D2-like dopamine receptor subtype selectivity and avenues for future treatment

Published:2023 Issue: Volume:9 Page:100212
ISSN:2590-1125
Container-title:Clinical Parkinsonism & Related Disorders
language:en
Short-container-title:Clinical Parkinsonism & Related Disorders

Author:

Isaacson Stuart H.,Hauser Robert A.,Pahwa Rajesh,Gray David,Duvvuri Sridhar

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Neurology (clinical)

Reference116 articles.

1. Parkinson's disease: from pathogenesis to pharmacogenomics;Cacabelos;Int. J. Mol. Sci.,2017

2. G.B.D. Neurology Collaborators, 2016, Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016, Lancet Neurol. 17 (11) (2018) 939–953.

3. The emerging evidence of the Parkinson pandemic;Dorsey;J. Parkinsons Dis.,2018

4. The Lewin Group, Inc. Economic Burden and Future Impact of Parkinson's Disease. Final Report. Updated 5 July 2019. Accessed 6 February 2023. https://www.michaeljfox.org/sites/default/files/media/document/2019%20Parkinson%27s%20Economic%20Burden%20Study%20-%20FINAL.pdf.

5. Projection of the prevalence of Parkinson's disease in the coming decades: Revisited;Rossi;Mov. Disord.,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroprotective effects of chlorogenic acid: Modulation of Akt/Erk1/2 signaling to prevent neuronal apoptosis in Parkinson's disease;Free Radical Biology and Medicine;2024-09

2. ENHANCING NOSE- TO- BRAIN DELIVERY OF PIRIBEDIL: DEVELOPMENT OF A NANOSUSPENSION DISPERSED IN NASAL IN-SITU GELLING SYSTEM;International Journal of Applied Pharmaceutics;2024-05-07

3. Dopamine Signaling in Substantia Nigra and Its Impact on Locomotor Function—Not a New Concept, but Neglected Reality;International Journal of Molecular Sciences;2024-01-17

4. Dopamine-Depleted Dopamine Transporter Knockout (DDD) Mice: Dyskinesia with L-DOPA and Dopamine D1 Agonists;Biomolecules;2023-11-17